Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2007 2
2008 3
2009 6
2010 6
2011 2
2012 4
2013 4
2014 1
2015 7
2016 5
2017 7
2018 6
2019 8
2020 2
2021 8
2022 6
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean marcio da silva (80 results)?
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
The therapeutic strategies against Naegleria fowleri.
Bellini NK, Santos TM, da Silva MTA, Thiemann OH. Bellini NK, et al. Among authors: da silva mta. Exp Parasitol. 2018 Apr;187:1-11. doi: 10.1016/j.exppara.2018.02.010. Epub 2018 Mar 1. Exp Parasitol. 2018. PMID: 29501696 Review.
The unique tRNASec and its role in selenocysteine biosynthesis.
Serrão VHB, Silva IR, da Silva MTA, Scortecci JF, de Freitas Fernandes A, Thiemann OH. Serrão VHB, et al. Among authors: da silva mta. Amino Acids. 2018 Sep;50(9):1145-1167. doi: 10.1007/s00726-018-2595-6. Epub 2018 Jun 12. Amino Acids. 2018. PMID: 29948343 Review.
25-hydroxyvitamin D in older adults: Which factors really matter?
Barbieri LB, da Silva MAC, de Souza Orlandi F, Dos Santos-Orlandi AA, Pavarini SCI, Gramani-Say K, de Oliveira Gomes GA, Zazzetta MS, Pott-Junior H. Barbieri LB, et al. Among authors: da silva mac. Geriatr Nurs. 2022 Mar-Apr;44:84-89. doi: 10.1016/j.gerinurse.2022.01.005. Epub 2022 Jan 26. Geriatr Nurs. 2022. PMID: 35092937
Mobile Robotic Platform for Contactless Vital Sign Monitoring.
Huang HW, Chen J, Chai PR, Ehmke C, Rupp P, Dadabhoy FZ, Feng A, Li C, Thomas AJ, da Silva M, Boyer EW, Traverso G. Huang HW, et al. Among authors: da silva m. Cyborg Bionic Syst. 2022;2022:9780497. doi: 10.34133/2022/9780497. Epub 2022 Apr 30. Cyborg Bionic Syst. 2022. PMID: 35571871 Free PMC article.
76 results